# Anixa Biosciences Inc: Form 4, filed Oct 26, 2026

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: 4
- Filed: 2026-10-26
- Accepted by EDGAR: Oct 26, 2026, 16:15 ET
- Period: 2026-10-23
- Accession: 0001493152-26-048520
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315226048520/xslF345X06/ownership.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315226048520/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315226048520/xslF345X06/ownership.xml

Filed Oct 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-048520. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.